ROX (Respiratory rate-OXygenation) index to predict early response to high-flow nasal cannula therapy in infants with viral bronchiolitis.

Christophe MilesiErika NogueJulien BaleineLionel MoulisRobin PouyauArthur Gavotto David W Brossier Guillaume Mortamet Cambonie Gillesnull null

Published in: Pediatric pulmonology (2024)

In this study, neither ROX index, nor physiological variables usually collected in infants with AVB had early discriminatory capacity to predict HFNC failure.

Keyphrases

sars cov
stem cells
respiratory syncytial virus
blood flow
bone marrow
replacement therapy